Amcor (AMCR) Q3 2024: Cost Actions Deliver $130M Savings as Volume Decline Narrows to 4%
Amcor’s third quarter saw decisive cost actions drive margin gains, even as top-line volumes remained pressured by lingering healthcare and beverage destocking. Flexibles and rigid packaging segments both returned to EBIT growth a quarter ahead of plan, with productivity initiatives and restructuring benefits offsetting continued softness in key categories. With cost leverage and sequential volume improvement, management raised full-year EPS guidance and signaled confidence in further earnings momentum into fiscal 2025.
Summary
- Cost Discipline Drives Margin Expansion: Structural and operational savings outpaced volume headwinds, supporting profit resilience.
- Volume Trajectory Improves, Led by Emerging Markets: Broad-based destocking abated, with 70% of the portfolio now stable or growing.
- Raised Guidance Signals Inflection: Management expects sequential earnings growth to continue as the business exits a challenging cycle.
Business Overview
Amcor is a global packaging leader, providing flexible and rigid packaging solutions for food, beverage, healthcare, and other consumer products. Revenue is generated through two main segments: Flexibles (film, pouches, and barrier packaging, about 70% of sales) and Rigid Packaging (bottles, closures, and specialty containers, about 30% of sales). The company’s model relies on scale, innovation in recyclable and sustainable materials, and long-term relationships with multinational and regional customers.
Performance Analysis
Amcor’s Q3 results underscore a clear inflection in both operational and financial performance. Adjusted EBIT returned to year-over-year growth, up 3% despite a 6% drop in net sales, reflecting a powerful combination of cost-out and productivity gains. Total cost savings reached $130 million in the quarter, with $15 million attributed to structural initiatives such as plant closures and permanent headcount reductions.
Volume headwinds narrowed, with overall Q3 volumes down 4% (versus -10% in Q2), driven primarily by ongoing destocking in healthcare and North American beverage, which together comprise about 30% of sales. The remaining 70% of the portfolio stabilized, with flat or slightly positive volume growth. Flexibles volumes improved from -10% to -2% sequentially, while rigids improved from -12% to -8%. Emerging markets led the rebound, posting low single-digit growth, while developed markets saw sequential improvement but remained below prior-year levels.
- Operating Leverage Delivers: EBIT margins expanded 170 basis points in Flexibles and 80 basis points in Rigids, as cost actions outpaced top-line declines.
- Cash Flow and Working Capital Strengthen: Free cash flow improved by $100 million year-to-date, with inventory reductions for the fifth consecutive quarter.
- Healthcare Remains a Drag: Double-digit volume declines in healthcare continue, but destocking is expected to abate into Q4 and early FY25.
Amcor’s ability to offset revenue pressure with disciplined execution and structural realignment positions the company for improved profitability as market conditions normalize.
Executive Commentary
"Outperformance in the underlying business resulted in adjusted earnings per share for the third quarter that exceeded the expectations we set out in February. Our flexible and rigid packaging segment each delivered adjusted EBIT growth, leading to Amcor returning to year-over-year earnings growth a quarter sooner than we anticipated."
Peter Conicci, Interim Chief Executive Officer
"We took another $130 million out of cost, which included some benefit from the restructuring program... We've been really both proactive and aggressive in flexing the cost base. As the volumes come back, we will have to put labor back into the business, rebuild shifts, but it's not going to be linear. So we expect that we will continue to see margin improvement."
Michael Casamento, Chief Financial Officer
Strategic Positioning
1. Structural Cost Reset
Amcor’s aggressive cost actions are proving durable, with permanent $50 million EBIT benefit targeted from restructuring, including plant closures and workforce reductions. Operational flexing—such as shift reductions and procurement savings—has enabled margin expansion even in a lower volume environment.
2. Portfolio Resilience and Mix Shift
Healthcare and North American beverage remain weak, but represent only 30% of sales. The balance of the portfolio (meat, cheese, pet food, emerging markets) is stabilizing or growing, providing a platform for recovery as destocking abates.
3. Innovation and Sustainability Commitment
Amcor continues to invest in recyclable and compostable packaging, with 90% of its portfolio now recycle-ready. The company reaffirmed its 2025 sustainability targets, setting it apart as some industry peers delay their own goals.
4. Capital Allocation and Shareholder Returns
Amcor maintains a disciplined capital return strategy, with $570 million returned via dividends and buybacks in the first nine months. Leverage remains within target range, and improved free cash flow supports ongoing returns.
5. Industry Leadership and Customer Relationships
Management emphasized Amcor’s scale advantage, diversified customer base, and strong positions in both developed and emerging markets, reinforcing the company’s ability to weather category-specific headwinds and capitalize on recovery trends.
Key Considerations
This quarter marks a turning point for Amcor, with sequential improvement in volumes, margin expansion, and visible progress on cost structure. Investors should weigh the durability of cost gains against the pace of demand recovery, particularly in healthcare and North American beverage.
Key Considerations:
- Emerging Markets Outperform: Sequential volume growth in Brazil, Mexico, Peru, China, Thailand, India, and the Philippines offsets developed market softness.
- Healthcare Drag Continues: Double-digit volume declines persist but are expected to moderate by early FY25 as destocking completes.
- Margin Expansion Is Structural: Permanent cost-outs and productivity gains are expected to sustain improved profitability as volumes normalize.
- Sustainability Progress Remains Differentiated: Amcor stays on track for 2025 recycle-ready targets, even as some peers reset timelines.
Risks
Persistent demand weakness in healthcare and North American beverage could delay full volume recovery, while any reversal in cost discipline or inflationary input shocks may compress margins. Regulatory changes in the EU (PPWR) and shifting customer sustainability targets create uncertainty for long-term product mix and capital requirements. Interest rate volatility remains a watchpoint, though Amcor’s debt profile is predominantly fixed through mid-2025.
Forward Outlook
For Q4, Amcor guided to:
- Mid-single-digit adjusted EPS growth (comparable constant currency)
- Volumes down low single digits, primarily due to healthcare destocking
For full-year 2024, management raised guidance:
- Adjusted EPS: 68.5 to 71 cents per share
- Adjusted free cash flow: $850 million to $950 million
Management highlighted several factors that will shape the outlook:
- Further cost savings in Q4 as structural initiatives are completed
- Continued sequential volume improvement as destocking abates
Takeaways
Amcor’s Q3 demonstrates that aggressive cost action can offset persistent category headwinds, positioning the company for improved profitability as demand stabilizes.
- Volume Inflection Confirmed: Sequential improvement across both segments, with 70% of the portfolio now stable or growing, signals a bottoming of volume declines.
- Cost Discipline Is Delivering: Structural and operational savings are translating to enduring margin expansion, even before full demand recovery.
- Watch for Healthcare and Beverage Normalization: The pace and breadth of recovery in these categories will determine the slope of top-line growth into FY25.
Conclusion
Amcor’s third quarter marks a clear shift from defense to recovery, as cost discipline and portfolio diversification mitigate continued category-specific weakness. With raised guidance and visible progress on key initiatives, the company enters the final quarter of the year with momentum and a credible path to earnings growth in fiscal 2025.
Industry Read-Through
Amcor’s results highlight a broader packaging sector trend: cost discipline and operational agility are critical as demand remains uneven across end markets. Destocking appears to be largely complete outside healthcare and beverage, suggesting that packaging peers with diversified portfolios and emerging market exposure may see similar volume stabilization. Persistent margin gains from structural cost actions may become the new baseline, raising the bar for competitors. Meanwhile, regulatory and sustainability shifts in Europe will increasingly differentiate leaders able to deliver recycle-ready solutions at scale.